Brian McLaughlin

558 total citations
16 papers, 405 citations indexed

About

Brian McLaughlin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Brian McLaughlin has authored 16 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Brian McLaughlin's work include Acute Myeloid Leukemia Research (2 papers), Lung Cancer Research Studies (2 papers) and Oral health in cancer treatment (2 papers). Brian McLaughlin is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Lung Cancer Research Studies (2 papers) and Oral health in cancer treatment (2 papers). Brian McLaughlin collaborates with scholars based in United States, United Kingdom and Canada. Brian McLaughlin's co-authors include Charles F. Halverson, Mary F. Waldrop, Richard Q. Bell, Clíona McDowell, Thelma Craig, Murali Shyamsundar, J.S. Elborn, Martin Duffy, Daniel F. McAuley and Claudy Mullon and has published in prestigious journals such as Science, Journal of Clinical Oncology and Annals of the New York Academy of Sciences.

In The Last Decade

Brian McLaughlin

14 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian McLaughlin United States 10 135 100 57 51 47 16 405
Diwakar D. Balachandran United States 16 129 1.0× 252 2.5× 183 3.2× 29 0.6× 36 0.8× 36 843
Marc Massanari United States 14 70 0.5× 413 4.1× 68 1.2× 36 0.7× 8 0.2× 43 926
Kathleen Moran United States 11 760 5.6× 47 0.5× 14 0.2× 19 0.4× 53 1.1× 21 1.1k
Karolina Müller Germany 13 84 0.6× 50 0.5× 62 1.1× 7 0.1× 8 0.2× 46 419
Simone Gambazza Italy 13 64 0.5× 208 2.1× 38 0.7× 44 0.9× 12 0.3× 66 464
Shuming Ji China 12 83 0.6× 60 0.6× 35 0.6× 13 0.3× 25 0.5× 54 462
Fernanda Rodrigues Brazil 13 36 0.3× 240 2.4× 29 0.5× 7 0.1× 20 0.4× 32 377
Mohd Razif Mohamad Yunus Malaysia 13 123 0.9× 119 1.2× 28 0.5× 19 0.4× 32 0.7× 73 414
Elizabeth A. Myers United States 10 98 0.7× 67 0.7× 84 1.5× 74 1.5× 3 0.1× 14 550
Jan Olofson Sweden 12 73 0.5× 224 2.2× 83 1.5× 32 0.6× 10 0.2× 21 440

Countries citing papers authored by Brian McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Brian McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian McLaughlin more than expected).

Fields of papers citing papers by Brian McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian McLaughlin. The network helps show where Brian McLaughlin may publish in the future.

Co-authorship network of co-authors of Brian McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Brian McLaughlin. A scholar is included among the top collaborators of Brian McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian McLaughlin. Brian McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Hong, Terry Evans, James G. Herman, et al.. (2024). Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy. Clinical Lung Cancer. 26(1). 78–81. 1 indexed citations
2.
Mushquash, Christopher J., et al.. (2024). Intravenous Drug Use in the Hospital Setting. Journal of Addictions Nursing. 35(4). 237–242.
3.
McLaughlin, Brian, et al.. (2023). Byzantine Greece: Microcosm of Empire?. University of Birmingham Research Portal (University of Birmingham).
4.
Giannetti, Vincent J., et al.. (2019). Ethics of chemotherapy during pregnancy. American Journal of Health-System Pharmacy. 76(4). 242–246. 2 indexed citations
5.
Im, Annie, Ali Imran Amjad, Mounzer Agha, et al.. (2016). Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 24(2). 73–80. 10 indexed citations
6.
Tarhini, Ahmad A., Haris Zahoor, Brian McLaughlin, et al.. (2013). Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer.. PubMed. 33(10). 4475–81. 23 indexed citations
7.
McLaughlin, Brian, Annie Im, Anastasios Raptis, et al.. (2012). Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy. International Journal of Hematology. 96(6). 743–747. 9 indexed citations
9.
Craig, Thelma, Martin Duffy, Murali Shyamsundar, et al.. (2009). Extravascular lung water indexed to predicted body weight is a novel predictor of intensive care unit mortality in patients with acute lung injury*. Critical Care Medicine. 38(1). 114–120. 95 indexed citations
10.
McLaughlin, Brian, Yongli Shuai, Ricardo L. Carrau, et al.. (2009). Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: The University of Pittsburgh experience. The Laryngoscope. 120(1). 71–75. 32 indexed citations
11.
McLaughlin, Brian, John C. Flíckinger, Dwight E. Heron, et al.. (2009). Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers. Annals of Oncology. 21(1). 145–151. 23 indexed citations
12.
Flannery, Thomas, et al.. (2008). Dialysis disequilibrium syndrome: a consideration in patients with hydrocephalus. Journal of Neurosurgery Pediatrics. 2(2). 143–145. 7 indexed citations
13.
McLaughlin, Brian, et al.. (1999). Overview of Extracorporeal Liver Support Systems and Clinical Results. Annals of the New York Academy of Sciences. 875(1). 310–325. 49 indexed citations
14.
McLaughlin, A.P., et al.. (1996). Noise levels in a cardiac surgical intensive care unit: a preliminary study conducted in secret. Intensive and Critical Care Nursing. 12(4). 226–230. 28 indexed citations
15.
Fong, I. W., et al.. (1987). Treatment of nongonococcal urethritis with ciprofloxacin.. PubMed. 82(4A). 311–6. 38 indexed citations
16.
Waldrop, Mary F., Richard Q. Bell, Brian McLaughlin, & Charles F. Halverson. (1978). Newborn Minor Physical Anomalies Predict Short Attention Span, Peer Aggression, and Impulsivity at Age 3. Science. 199(4328). 563–565. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026